Assembly Biosciences, Inc. Operating Leases, Rent Expense
Assembly Biosciences, Inc. (ASMB) reported Operating Leases, Rent Expense of $4.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-28
- Assembly Biosciences, Inc. operating leases, rent expense for the quarter ending 2018-12-31 was $2.90M, a 190.00% increase year-over-year.
- Assembly Biosciences, Inc. operating leases, rent expense for the quarter ending 2018-09-30 was $500.00K, a 25.00% increase year-over-year.
- Assembly Biosciences, Inc. operating leases, rent expense for the quarter ending 2018-06-30 was $400.00K, a 33.33% increase year-over-year.
- Assembly Biosciences, Inc. operating leases, rent expense for the quarter ending 2018-03-31 was $400.00K, a 33.33% increase year-over-year.
- Assembly Biosciences, Inc. operating leases, rent expense for fiscal 2018 was $4.20M, a 100.00% increase from fiscal 2017.
- Assembly Biosciences, Inc. operating leases, rent expense for fiscal 2017 was $2.10M, a 10.53% increase from fiscal 2016.
- Assembly Biosciences, Inc. operating leases, rent expense for fiscal 2016 was $1.90M, a 171.43% increase from fiscal 2015.
- Assembly Biosciences, Inc. operating leases, rent expense for fiscal 2015 was $700.00K, a 250.00% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 1 month | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 9 month as first filed | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.40M derived: sum of 2 quarters · filed 2019-02-28 | $3.80M derived: sum of 3 quarters · filed 2019-02-28 | $4.20M 10-K · filed 2019-02-28 | |||||
| 2018-09-30 | $500.00K 10-Q · filed 2018-11-08 | $900.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.30M 10-Q · filed 2018-11-08 | $2.30M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2018-06-30 | $400.00K 10-Q · filed 2018-08-08 | $800.00K 10-Q · filed 2018-08-08 | $1.80M derived: sum of 3 quarters · filed 2019-02-28 | $2.20M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2018-03-31 | $400.00K 10-Q · filed 2018-05-07 | $1.40M derived: sum of 2 quarters · filed 2019-02-28 | $1.80M derived: sum of 3 quarters · filed 2019-02-28 | $2.10M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.40M derived: sum of 2 quarters · filed 2019-02-28 | $1.70M derived: sum of 3 quarters · filed 2019-02-28 | $2.10M 10-K · filed 2019-02-28 | $1.30M 10-K · filed 2018-03-08 | ||||
| 2017-09-30 | $400.00K 10-Q · filed 2018-11-08 | $700.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.10M 10-Q · filed 2018-11-08 | $1.80M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-08 | $600.00K 10-Q · filed 2018-08-08 | $1.40M derived: sum of 3 quarters · filed 2019-02-28 | $1.70M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2017-03-31 | $300.00K 10-Q · filed 2018-05-07 | $1.10M derived: sum of 2 quarters · filed 2019-02-28 | $1.40M derived: sum of 3 quarters · filed 2019-02-28 | $1.80M derived: sum of 4 quarters · filed 2019-02-28 | |||||
| 2016-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $1.10M derived: sum of 2 quarters · filed 2019-02-28 | $1.50M derived: sum of 3 quarters · filed 2019-02-28 | $1.90M 10-K · filed 2019-02-28 | $1.20M 10-K · filed 2017-03-02 | ||||
| 2016-09-30 | $300.00K 10-Q · filed 2017-11-01 | $318.00K 10-Q · filed 2016-11-09 | $700.00K derived: sum of 2 quarters · filed 2017-11-01 | $1.10M 10-Q · filed 2017-11-01 | $1.24M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | $400.00K 10-Q · filed 2017-08-09 | $402.64K 10-Q · filed 2016-08-09 | $800.00K 10-Q · filed 2017-08-09 | $755.00K 10-Q · filed 2016-08-09 | $944.00K derived: sum of 3 quarters · filed 2018-03-08 | $1.10M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-03-31 | $300.00K 10-Q · filed 2017-05-08 | $544.00K derived: sum of 2 quarters · filed 2018-03-08 | $703.00K derived: sum of 3 quarters · filed 2018-03-08 | $841.00K derived: sum of 4 quarters · filed 2018-03-08 | |||||
| 2015-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $403.00K derived: sum of 2 quarters · filed 2018-03-08 | $541.00K derived: sum of 3 quarters · filed 2018-03-08 | $700.00K 10-K · filed 2018-03-08 | |||||
| 2015-09-30 | $159.00K 10-Q · filed 2016-11-09 | $70.41K 10-Q · filed 2015-11-09 | $297.00K derived: sum of 2 quarters · filed 2016-11-09 | $456.00K 10-Q · filed 2016-11-09 | $171.22K 10-Q · filed 2015-11-09 | ||||
| 2015-06-30 | $138.00K 10-Q · filed 2016-08-09 | $297.00K 10-Q · filed 2016-08-09 | |||||||
| 2015-03-31 | $100.00K 10-Q · filed 2016-05-10 | $8.40K 10-Q · filed 2015-05-08 | |||||||
| 2015-01-31 | $36.15K 10-Q · filed 2015-05-08 | ||||||||
| 2014-12-31 | $200.00K 10-K · filed 2016-03-11 | $8.40K 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |